Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Negamycin inhibits termination of protein synthesis directed by phage f2 RNA in vitro.

× No keyword cloud information.

7 in total

1. Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome.

Authors: Nelson B Olivier; Roger B Altman; Jonas Noeske; Gregory S Basarab; Erin Code; Andrew D Ferguson; Ning Gao; Jian Huang; Manuel F Juette; Stephania Livchak; Matthew D Miller; D Bryan Prince; Jamie H D Cate; Ed T Buurman; Scott C Blanchard
Journal: Proc Natl Acad Sci U S A Date: 2014-11-03 Impact factor: 11.205

2. Ribosomal function and its inhibition by antibiotics in prokaryotes.

Authors: K H Nierhaus; H G Wittmann
Journal: Naturwissenschaften Date: 1980-05

3. Negamycin analogue with readthrough-promoting activity as a potential drug candidate for duchenne muscular dystrophy.

Authors: Akihiro Taguchi; Shigenobu Nishiguchi; Masataka Shiozuka; Takao Nomoto; Mayuko Ina; Shouta Nojima; Ryoichi Matsuda; Yoshiaki Nonomura; Yoshiaki Kiso; Yuri Yamazaki; Fumika Yakushiji; Yoshio Hayashi
Journal: ACS Med Chem Lett Date: 2012-01-02 Impact factor: 4.345

4. Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.

Authors: David C McKinney; Gregory S Basarab; Alexis I Cocozaki; Melinda A Foulk; Matthew D Miller; Anatoly M Ruvinsky; Clay W Scott; Kumar Thakur; Liang Zhao; Ed T Buurman; Sridhar Narayan
Journal: ACS Med Chem Lett Date: 2015-07-12 Impact factor: 4.345

Negamycin inhibits termination of protein synthesis directed by phage f2 RNA in vitro.

1. Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome.

2. Ribosomal function and its inhibition by antibiotics in prokaryotes.

3. Negamycin analogue with readthrough-promoting activity as a potential drug candidate for duchenne muscular dystrophy.

4. Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.

5. Antitumor activity and mechanism of action of the marine compound girodazole.

6. The Antibiotic Negamycin Crosses the Bacterial Cytoplasmic Membrane by Multiple Routes.

7. Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA.